Omalizumab treatment for chronic spontaneous urticaria: data from Turkey

AIM: The aim of the study was to investigate data from patients suffering from chronic spontaneous urticaria refractory to conventional therapy, and to document outcomes of omalizumab use. MATERIAL AND METHODS: We conducted a single-centre retrospective study with 175 chronic spontaneous urticaria p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kara, Rabia Oztas, Dikicier, Bahar Sevimli, Yaldiz, Mahizer, Koku, Busra, Çosansu, Nur Cihan, Solak, Berna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454344/
https://www.ncbi.nlm.nih.gov/pubmed/36090713
http://dx.doi.org/10.5114/ada.2021.109081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454344/
https://www.ncbi.nlm.nih.gov/pubmed/36090713
http://dx.doi.org/10.5114/ada.2021.109081

Ejemplares similares